Mediators of nasal allergy.
D000287:Administration, Topical; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001491:Basophils / Q000276:immunology; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D004205:Cromolyn Sodium / Q000627:therapeutic use; D005938:Glucocorticoids; D000882:Haplorhini; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008407:Mast Cells / Q000276:immunology; D009297:Nasal Mucosa / Q000033:anatomy & histology / Q000098:blood supply / Q000294:innervation; D009299:Nasal Provocation Tests; D009466:Neuromuscular Blocking Agents / Q000627:therapeutic use; D010275:Parasympathetic Nervous System / Q000098:blood supply; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000098:blood supply
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000893:Anti-Inflammatory Agents; D002121:Calcium Channel Blockers; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D006993:Hypnotics and Sedatives; D009466:Neuromuscular Blocking Agents; D004205:Cromolyn Sodium